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In 2015, APS Council and the APS Publications Committee, the latter led by 
Dr. Curt D. Sigmund, began an initiative on the transparency of research 
reporting in the APS Journals. At this time, concerns over biosciences 
research reproducibility, especially in areas such as pre-clinical cancer 
biology research, had become prominent [2, 7, 8]. As of 2017, multiple 
funding bodies, including the USA National Institutes of Health, have 
reconfigured their instructions for preparation of grant applications to give 
more emphasis to methodology, experimental design and the validation of key 
reagents [e.g., NIH: grants.nih.gov/reproducibility/index.html; UK Medical 
Research Council: www.mrc.ac.uk/documents/pdf/methodology-and-
experimental-design-in-applications-guidance-for-reviewers-and-applicants/ ].   
 
The APS initiative included discussions between the Publications Committee, 
Editors of APS Journals and Editorial Advisory Board members on how 
guidance to authors for manuscript preparation could be aligned with the over-
arching goal of enhancing the likelihood of research reproducibility. The 
discussions highlighted the central issue that any attempt at research 
reproduction (or extension) depends on access to sufficient information on the 
reagents, experimental procedures and statistical analyses utilised in the 
initial research study. Thus one major outcome was that in August 2016 the 
APS Journals updated their Instructions to Authors for manuscript and figure 
preparation. At the start of 2017, new questions for reviewers were introduced 
as part of the peer-review process for original research manuscripts.  In this 
Editorial, I will discuss areas of Methods reporting that are of particular 
relevance to AJP-Cell Physiology and offer some points of guidance to 
potential authors. Of course, there are many aspects of reagent choice and 
experimental design that may affect the likelihood of research reproducibility. 
Several “hot-button” topics, including the selectivity of pharmacological 
inhibitors, or the specificity and reliability of commercial antibodies, have been 
addressed recently in AJP-Cell Physiology and will not be not covered further 
here [4, 10]. 
 
Many readers of this editorial will be familiar with training graduate students to 
question their reagents, to be meticulous and timely with record-keeping, and 
to present comprehensive explanations on methods, reagents and statistical 
analyses when writing a research thesis. Nevertheless, this level of detail is 
far removed from the abbreviated style of methods writing that has come to 
predominate in modern bioscience research papers. From the beginning of 
the APS discussions, it was clear that certain practices in research reporting 
were and are a source of frustration for many Editors. Based on outcomes 
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from the APS discussions a new section has been included in the online APS 
Information for Authors, “Experimental Details to Report in Your Manuscript” 
(www.the-aps.org/mm/Publications/Info-For-Authors/Experimental-Details-to-
Report). Extended background information is also provided in another new 
section “Promoting Transparent Reporting”   (http://www.the-
aps.org/mm/Publications/Info-For-Authors/Promoting-Transparent-Reporting). 
Prospective authors are strongly advised to consult both of these sections, 
which set out, in a clear and concise way, certain general expectations for 
quality control and depth of explanation for methods involving cell lines, 
antibodies, vertebrate animals, or samples from humans. Minimum standards 
for reporting on the sources of reagents, the presentation of immunoblots, 
statistical analyses, mathematical models, or the availability of computer code 
are covered, along with best practice expectations for the handling and 
presentation of digital images.  
 
These are all “common-sense” reporting procedures for researchers and 
prospective authors are presently encouraged to adopt these practices. The 
peer-review policy of APS is that manuscripts are accepted based on their 
scientific content and the presentation of the material.  At AJP-Cell 
Physiology, we wish to promote especially the transparency of reporting for 
reagents and methods that are core technologies for cell-centric research. For 
example, in view of the importance of cell lines, strains and primary cultures in 
many papers published herein, we aim to promote transparency of research 
reporting of variables related to cell cultures. Articles in AJP-Cell Physiology 
have emphasised the need to report the sex of your cells in the Methods 
section [12, 13]. Another methodology that features in many AJP-Cell 
Physiology papers is immunoblotting: we expect to see appropriate 
quantification from immunoblots [9] and the Information for Authors also 
provides detailed guidance on how immunoblot panels should be annotated. 
Where needed, we will ask authors to make final minor figure or text 
corrections before acceptance for publication.  
 
Looking ahead into 2017 and beyond, what other aspects of data presentation 
would further improve transparency of reporting at AJP-Cell Physiology? 
Many papers published in AJP-Cell Physiology present data from multiple 
independent experiments in the form of bar graphs that display the mean, -/+ 
standard deviation or standard error of the mean [3]. More general use of the 
box-and-whisker plot or its variants [6] at AJP-Cell Physiology would provide 
better transparency on the distribution of the underlying data.  As the APS 
Journal that is focused on Cell Physiology, AJP-Cell Physiology also receives 
many manuscripts that address questions of molecular localisation and/or co-
localisation in cells, often demonstrated by presentation of digitally-merged, 
confocal fluorescence microscopy images. Aside from the general debate on 
the most meaningful method(s) to demonstrate molecular co-localisation, 
current digital imaging and post-acquisition image analysis software provide 
many valuable options for quantified analysis of co-localisation from confocal 
microscopy: we encourage authors submitting to AJP-Cell Physiology to 
embrace these methods.  For transparency of reporting, the rationale for the 
metric chosen, the parameter settings applied, and the tests conducted to 
assess datapoint distribution [5] need to be stated in the Methods section.  
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In January 2017, the “Reproducibility Project: Cancer Biology” published the 
results from its first five projects. These showed mixed success in research 
replication [11]. Clearly, transparency of reporting is only one aspect of good 
research practice that may improve research reproducibility and robustness 
[1], yet it is a rational step that can be applied with clear objectives. For AJP-
Cell Physiology to meet the goal of enhanced transparency of research 
reporting will need concerted, stringent, yet benevolent, input from authors, 
reviewers and editors. Authors should reap benefits when preparing 
transparency materials for funding applications. For reviewers, the additional 
questions on the review form aim to make checking of central areas of 
transparent reporting systematic across all manuscripts. I hope that all 
contributors to AJP-Cell Physiology will be willing to “step up to the plate”. I 
thank the authors, reviewers and editors who are already putting into practice 
careful attention to methods reporting. Recent surveys in the USA and the UK 
attest that scientists are some of the most esteemed [14] or trusted [15] 
professionals. Striving to increase transparency is a contribution we can make 
to further strengthen rational, evidence-based advancement of knowledge.  
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